Products & Solutions
Back
Products & Solutions
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Protein Chemistry
Workflow & Informatics
Automation Systems Clinical Information Management Tools PROService Remote Service Tool DxONE Inventory Manager Instrument Aggregator Middleware Data Analytics
Solutions For
SARS-CoV-2 Antibody Testing Anemia Cardiovascular Disease Diabetes Diagnostics Drug Monitoring & Detection Prostate Cancer Detection Reproductive Health Sepsis Life Sciences ›
Service promo banner
Support
Back
Support
Account Support
Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Training Courses › Register for Training ›
Education & Research
Webinars Posters 3D Virtual Laboratory Showcase
Insights
Clinical Studies & Trends Case Studies Publications
Lab order management systems
Company
Back
Company
People & Culture
Overview Meet Our Teams Diversity + Inclusion How We Work Innovation
Careers
Job Search › Career Stories Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar


Global Impact of Sepsis

Sepsis, a life-threatening organ dysfunction, is caused by a dysregulated host immune response to infection. Sepsis affects more than 49 million people worldwide.1 Identifying the root cause of infection and optimizing antibiotic use is essential to ensure a successful outcome, reduce adverse antibiotic effects, and prevent antibiotic resistance.2
A life-threatening syndrome
0
  • A dysregulated immune response to infection
  • Requires immediate treatment
  • Can progress to septic shock and lead to organ dysfunction and death
A global healthcare crisis
0
  • Responsible for more than 11 M global deaths, annually1
  • The leading cause of hospital readmissions3
  • Accounts for more hospitalization costs than any other disease4
A treatable condition
0
  • Early and appropriate administration of antibiotics decreases sepsis mortality
  • Prompt antibiotics administration improves sepsis outcomes

The Sepsis Patient Pathway Is Complicated

Let Beckman Coulter Solutions Be Your Guide

Sepsis can cause devastating patient consequences and drive significant healthcare costs. Timely administration of antibiotics to patients with sepsis decreases the likelihood of death. Supporting better patient outcomes across their journey requires a broad and comprehensive approach.

See one patient’s journey from initial assessment in the Emergency Department through treatment in the Intensive Care Unit to eventual discharge.

Download infographic ››

Knowledge in Practice

For septic patients, IVD testing is crucial to support effective treatment. Testing can be done using many different biomarkers and systems belonging to different laboratory disciplines.
What if you could act faster and avoid patient health deterioration? Watch these on-demand webinars to learn more about the tools used to identify
sepsis to bring treatments to patients faster.

Supporting Better Outcomes for All Patients

Timely treatment is the foundation to successful sepsis intervention, so early sepsis diagnosis is critical. Learn more about our commitment to
early sepsis diagnosis and antimicrobial stewardship.

One of the main concerns on the management of patients with sepsis and septic shock is the augmentation of antimicrobial efficacy, while preventing the emergence of resistant strains during treatment.
Martinez et al.2

 

Explore Solutions for Sepsis Patient Management

1. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7

2. Martínez ML, Plata-Menchaca EP, Ruiz-Rodríguez JC, Ferrer R. An approach to antibiotic treatment in patients with sepsis. J Thorac Dis. 2020;12(3):1007-1021. doi:10.21037/jtd.2020.01.47

3. Fact Sheets | Sepsis Alliance. 2023. Accessed August 10, 2023. https://www.sepsis.org/education/resources/fact-sheets/

4. Perman SM, Goyal M, Gaieski DF. Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med. 2012;20:41. doi:10.1186/1757-7241-20-41

 

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.